Work

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

Year: 2013

Type: article

Source: European Heart Journal

DOI: 10.1093/eurheartj/eht445

Authors: J. H. Alexander, R. D. Lopes, L. Thomas, M. Alings, D. Atar, P. Aylward, S. Goto, M. Hanna, K. Huber, S. Husted, B. S. Lewis, J. J. V. McMurray, P. Pais, H. Pouleur, P. G. Steg, F. W. A. Verheugt, D. M. Wojdyla, C. B. Granger, L. Wallentin

Institutions: Duke Medical Center, Duke Clinical Research Institute, Werkgroep Cardiologische centra Nederland, Oslo University Hospital, Tokai University, Bristol-Myers Squibb (United States), Wilhelminen Hospital, Aarhus University, Carmel Medical Center, University of Glasgow, St.John's Medical College Hospital, Pfizer (United States), Hôpital Bichat-Claude-Bernard, Radboud University Nijmegen, Radboud University Medical Center, Uppsala University

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, Duke Clinical Research Institute

OpenAlex ID: W2163974509

FWCI: 12.7

Cites: 37

Cited by: 156

Related to: 10